| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |